| Identification | Back Directory | [Name]
4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-6-[methyl[3-(1-piperazinyl)propyl]amino]- | [CAS]
2883407-81-4 | [Synonyms]
FAPI 46 without DOTA
(S)-N-(2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)-6-(methyl(3-(piperazin-1-yl)propyl)amino)quinoline-4-carboxamide
4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-6-[methyl[3-(1-piperazinyl)propyl]amino]- | [Molecular Formula]
C25H31F2N7O2 | [MOL File]
2883407-81-4.mol | [Molecular Weight]
499.56 |
| Chemical Properties | Back Directory | [Boiling point ]
804.1±65.0 °C(Predicted) | [density ]
1.34±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
12.48±0.46(Predicted) | [color ]
Light yellow to yellow |
| Hazard Information | Back Directory | [Uses]
FT-FAPI-12_9 is a FAP-binding moiety, which can be used for synthesis of FAP-targeted radiotracer FAPI-46 (HY-137331)[1]. | [References]
[1] Jaafar Thiel, et al., Fibroblast activation protein (fap) inhibitors, fap conjugates, and diagnostic and therapeutic uses thereof. WO2024064968 A1 |
|
| Company Name: |
YantaiBio
|
| Tel: |
13758194781 |
| Website: |
|
|